|
16 Aug 2023
|
Venus Remedies
|
Keynotes Financial Opiniery
|
455.95
|
307.00
|
265.60
(71.67%)
|
Target met |
Buy
|
|
|
The Indian pharmaceutical and healthcare sector is anticipated to register a growth of 8-10% in FY24. Pharmaceutical businesses will continue to reassess the risk of their dependencies on global supply chains, given the resurfacing of the COVID-19 pandemic in some nations and the recent Russia-Ukraine war that has significantly impacted the operations of pharmaceutical companies globally.
|